(Q62031116)
Statements
Phase I Double Blind Placebo Controlled Safety Study of ex Vivo Treatment of Kidneys From Deceased Donors With Renaparin®, Followed by Transplantation to Study Population (English)
0 references
11 December 2018
0 references
April 2019
0 references
18
0 references
18 year
0 references
75 year
0 references